Padraig Mcdonnell

President and Chief Executive Officer, Agilent

Search every verified Padraig Mcdonnell interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Padraig McDonnell, President and CEO of Agilent Technologies, discussed the company's outlook during an appearance on CNBC's "Closing Bell Overtime" on July 17, 2025, following the company's investor day. McDonnell described the current period as a "golden age of biology and science" and stated that Agilent sees a "long runway" in advancing therapeutics. He noted that the healthcare market is "coming back slowly" and expects recovery to continue into 2025 and 2026. McDonnell identified artificial intelligence capabilities and "cutting edge science" in areas such as PFAS testing as key innovations for the company. Regarding the incoming Trump administration, McDonnell said he sees "more tailwinds than headwinds," citing potential increases in FDA approvals and regulations around PFAS. On China, which accounts for 20% of Agilent's revenue, McDonnell emphasized the importance of being "in China for China" with local manufacturing capabilities and strong technical teams. He described the pathology business as "durable" with mid- to high-single-digit growth, particularly in cancer testing.